The role of neoadjuvant aromatase inhibitors in ER / PR positive HER-2 neu negative in postmenopausal females with locally advanced breast cancer / Heba Aly Mohamed Ateya ; Supervised Heba M. Elzawahry , Nadia Mahmoud Mokhtar , Osman M. Mansour
Material type:
TextLanguage: English Publication details: Cairo : Heba Aly Mohamed Ateya , 2013Description: 188 P. ; 25cmOther title: - دور مثبطات الارومازين فى العلاج ما قبل الجراحة فى حالات فى حالات سرطان الثدى المتقدم موضعيا فى السيدات بعد سن الياس ذوات مستقبلات الاستروجين / البروجستيرون الموجبة والهيرتو نيو السالبة [Added title page title]
- Issued also as CD
| Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
|---|---|---|---|---|---|---|---|
Thesis
|
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.Ph.D.2013.He.R (Browse shelf(Opens below)) | Not for loan | 01010110061530000 | ||
CD - Rom
|
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.Ph.D.2013.He.R (Browse shelf(Opens below)) | 61530.CD | Not for loan | 01020110061530000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology (Medical)
Background: In Egypt female breast cancer ranks as the first malignancy affecting females (37.5% in NCI Egypt). Approximately 20% to 25% of breast cancer patients present with locally advanced disease. Methods : this is a prospective study including fifty two female postmenopausal patients with newly diagnosed LABC, they receive 4 months of neoadjuvant aromatase inhibitor (letrozole) 2.5 mg daily followed by clinical and radiological evaluation, if they have at least partial response, they will be refered to surgery
Issued also as CD
There are no comments on this title.
Click on an image to view it in the image viewer